Works matching IS 00099236 AND DT 2025 AND VI 117 AND IP 1

Results: 34
    1

    Highlighted Articles.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 14, doi. 10.1002/cpt.3490
    Publication type:
    Article
    2

    An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 225, doi. 10.1002/cpt.3431
    By:
    • Zhou, Di;
    • Kischel, Roman;
    • Stienen, Sabine;
    • Townsley, Danielle;
    • Sternjak, Alexander;
    • Lutteropp, Michael;
    • Bailis, Julie;
    • Friedrich, Matthias;
    • Rattel, Benno;
    • Mehta, Khamir;
    • Upreti, Vijay V.
    Publication type:
    Article
    3
    4
    5
    6

    In This Issue.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 9, doi. 10.1002/cpt.3488
    Publication type:
    Article
    7
    8

    ASCPT News.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 16, doi. 10.1002/cpt.3486
    Publication type:
    Article
    9
    10

    Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 116, doi. 10.1002/cpt.3460
    By:
    • Donnelly, Mark;
    • Fang, Lanyan;
    • Madabushi, Rajanikanth;
    • Zhu, Hao;
    • Luke, Markham;
    • Canterbury, Crystal;
    • Lerman, Bruce;
    • Kaur, Paramjeet;
    • Patel, Devvrat;
    • Sun, Wanjie;
    • Schuirmann, Don;
    • Dinsmore, Steven;
    • Mehta, Mehul;
    • Zhao, Liang
    Publication type:
    Article
    11
    12

    Value of Pharmacogenetic Testing Assessed with Real‐World Drug Utilization and Genotype Data.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 278, doi. 10.1002/cpt.3458
    By:
    • Litonius, Kaisa;
    • Kulla, Noora;
    • Falkenbach, Petra;
    • Kristiansson, Kati;
    • Tarkiainen, E. Katriina;
    • Ukkola‐Vuoti, Liisa;
    • Cajanus, Kristiina;
    • Korhonen, Mari;
    • Khan, Sofia;
    • Sistonen, Johanna;
    • Orpana, Arto;
    • Lindstedt, Mats;
    • Nyrönen, Tommi;
    • Perola, Markus;
    • Turpeinen, Miia;
    • Kytö, Ville;
    • Tornio, Aleksi;
    • Niemi, Mikko
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 34, doi. 10.1002/cpt.3439
    By:
    • Nagaraja Shastri, Prathap;
    • Shah, Nirav;
    • Lechmann, Martin;
    • Mody, Hardik;
    • Retter, Marc W.;
    • Zhu, Min;
    • Li, Tommy;
    • Wang, Jun;
    • Shaik, Naveed;
    • Zheng, Xirong;
    • Ovacik, Meric;
    • Hua, Fei;
    • Jawa, Vibha;
    • Boetsch, Christophe;
    • Cao, Yanguang;
    • Burke, John;
    • Datta, Kaushik;
    • Gadkar, Kapil;
    • Upreti, Vijay;
    • Betts, Alison
    Publication type:
    Article
    21
    22
    23

    A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta‐Lactamase Inhibition.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 193, doi. 10.1002/cpt.3423
    By:
    • Schouwenburg, Stef;
    • Keij, Fleur M.;
    • Tramper‐Stranders, Gerdien A.;
    • Kornelisse, René F.;
    • Reiss, Irwin K. M.;
    • De Cock, Pieter A. J. G.;
    • Dhont, Evelyn;
    • Watt, Kevin M.;
    • Muller, Anouk E.;
    • Flint, Robert B.;
    • Koch, Birgit C. P.;
    • Allegaert, Karel;
    • Preijers, Tim
    Publication type:
    Article
    24

    Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 184, doi. 10.1002/cpt.3421
    By:
    • Leegwater, Emiel;
    • Baidjoe, Lauren;
    • Wilms, Erik B.;
    • Visser, Leo G.;
    • Touw, Daniel J.;
    • de Winter, Brenda C. M.;
    • de Boer, Mark G. J.;
    • van Paassen, Judith;
    • van den Berg, Charlotte H. S. B.;
    • van Prehn, Joffrey;
    • van Gelder, Teun;
    • Moes, Dirk Jan A. R.
    Publication type:
    Article
    25
    26
    27
    28
    29

    Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 28, doi. 10.1002/cpt.3416
    By:
    • Lockwood, Christina M.;
    • Merker, Jason D.;
    • Bain, Elizabeth;
    • Compton, Caroline;
    • Grossman, Robert L.;
    • Johann, Donald;
    • Jones, Frederick;
    • Jones, Gregory;
    • Kreifels, Matthew;
    • LeBlang, Suzanne;
    • Lee, Jerry S.H.;
    • Lyle, John;
    • Martini, Jean‐Francois;
    • Saunders, Lauren;
    • Scher, Howard;
    • Somiari, Stella;
    • Stewart, Mark;
    • Vinson, Jacob;
    • Leiman, Lauren C.
    Publication type:
    Article
    30
    31
    32
    33

    Issue Information.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 1, doi. 10.1002/cpt.3317
    Publication type:
    Article
    34

    Questioning Conclusions and Statements on the German HTA System: A Critical Perspective.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 22, doi. 10.1002/cpt.3296
    By:
    • Tomeczkowski, Jörg;
    • Heidbrede, Tanja;
    • Leverkus, Friedhelm;
    • Schmitter, Sarah;
    • Dintsios, Charalabos‐Markos;
    • Osowski, Ulrike;
    • Herrmann, Kirsten H.;
    • Bluhmki, Tobias;
    • Marx, Almuth;
    • Eichinger, Birte;
    • Basic, Edin;
    • Bussilliat, Paul;
    • Dietrich, Eva Susanne
    Publication type:
    Article